JP2568846C - - Google Patents
Info
- Publication number
- JP2568846C JP2568846C JP2568846C JP 2568846 C JP2568846 C JP 2568846C JP 2568846 C JP2568846 C JP 2568846C
- Authority
- JP
- Japan
- Prior art keywords
- myoglobin
- blood
- adsorbent
- water
- adsorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000036913 Myoglobin Human genes 0.000 claims description 41
- 108010062374 Myoglobin Proteins 0.000 claims description 41
- 239000003463 adsorbent Substances 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 14
- 239000011148 porous material Substances 0.000 claims description 12
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 6
- 229920001577 copolymer Polymers 0.000 claims description 6
- -1 Taacrylonitrile Chemical compound 0.000 claims description 5
- VVQNEPGJFQJSBK-UHFFFAOYSA-N 2-methyl-2-propenoic acid methyl ester Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 210000002381 Plasma Anatomy 0.000 description 14
- 210000001124 Body Fluids Anatomy 0.000 description 11
- 239000010839 body fluid Substances 0.000 description 8
- 239000000306 component Substances 0.000 description 8
- 238000001914 filtration Methods 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000002245 particle Substances 0.000 description 4
- 102100001249 ALB Human genes 0.000 description 3
- 101710027066 ALB Proteins 0.000 description 3
- 210000001772 Blood Platelets Anatomy 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- 229940050528 albumin Drugs 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GYCMBHHDWRMZGG-UHFFFAOYSA-N 2-cyanopropene-1 Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 2
- 210000000601 Blood Cells Anatomy 0.000 description 2
- 102000018358 Immunoglobulins Human genes 0.000 description 2
- 108060003951 Immunoglobulins Proteins 0.000 description 2
- 210000003205 Muscles Anatomy 0.000 description 2
- 206010038435 Renal failure Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 201000009910 diseases by infectious agent Diseases 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000000268 renotropic Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N 2-hydroxyethyl 2-methylacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010062599 Arterial occlusive disease Diseases 0.000 description 1
- ORWQQPIZRZZEIH-UHFFFAOYSA-N C=CC1=CC=C[N-]1 Chemical compound C=CC1=CC=C[N-]1 ORWQQPIZRZZEIH-UHFFFAOYSA-N 0.000 description 1
- 102000000989 Complement System Proteins Human genes 0.000 description 1
- 108010069112 Complement System Proteins Proteins 0.000 description 1
- 206010050702 Crush syndrome Diseases 0.000 description 1
- 208000002230 Diabetic Coma Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229940088597 Hormone Drugs 0.000 description 1
- 208000002762 Hypoproteinemia Diseases 0.000 description 1
- 229940072221 IMMUNOGLOBULINS Drugs 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 206010038436 Renal failure acute Diseases 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 230000001154 acute Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 description 1
- 239000005043 ethylene-methyl acrylate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002209 hydrophobic Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002484 inorganic compounds Chemical group 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000002616 plasmapheresis Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001172 regenerating Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2590225C2 (ru) | Полимерная система, обладающая селективностью адсорбции по размерам | |
| EP2155285B1 (fr) | Polymères adsorbants d'hémoperfusion à sélection de taille | |
| EP2981308B1 (fr) | Modificateurs d'hémocompatibilité pour matériau polymère réticulé | |
| EP1115456A2 (fr) | Procede pour retirer la beta-2-microglobuline contenue dans le sang | |
| EP1621220A1 (fr) | Adsorbant de lipoproteine/fibrinogene de faible densite et appareil d'adsorption permettant un traitement du sang total | |
| GB2025385A (en) | Activated carbon and apparatus for hemoperfusion | |
| US20070077555A1 (en) | Adsorption system for the removal of viruses and viral components from fluids, in particular blood and blood plasma | |
| JP2568846B2 (ja) | ミオグロビン吸着材 | |
| JP3633979B2 (ja) | エンドトキシンの吸着剤、吸着除去方法および吸着器 | |
| JP2568846C (fr) | ||
| JP2534867B2 (ja) | ミオグロビン吸着材 | |
| JPH0549694A (ja) | 造影剤の吸着体 | |
| JP3272099B2 (ja) | ブラジキニン吸着体 | |
| JP3192711B2 (ja) | 造影剤用の吸着体 | |
| JPH01181875A (ja) | 免疫複合体の吸着体およびそれを用いた免疫複合体の除去装置 | |
| JP3330420B2 (ja) | ブラジキニンの吸着体 | |
| JP3633978B2 (ja) | 腫瘍壊死因子−αの吸着剤、吸着除去方法および吸着器 | |
| JP3214632B2 (ja) | 血液浄化用吸着体 | |
| JPH07289633A (ja) | 除去器及び除去装置 | |
| JPS62261367A (ja) | β２ミクログロブリンの吸着剤 | |
| JPS6259976B2 (fr) | ||
| JPH0246858A (ja) | 体液処理装置 | |
| JPH043988B2 (fr) | ||
| JPS5826819A (ja) | 多孔性ガラスからなる低密度リポ蛋白質吸着剤 | |
| JPH10179732A (ja) | 全血処理装置及び全血処理方法 |